Tanja A. Gruber

Chambers Family Endowed Professor for Pediatric Cancer

Clinical Focus

Pediatrics
Oncology

Academic Appointments

Professor - University Medical Line, Pediatrics - Hematology & Oncology
Member, Stanford Cancer Institute

Administrative Appointments

Division Chief, Pediatric Hematology, Oncology, Stem Cell Transplantation & Regenerative Medicine (2020 - Present)
Director, Bass Center for Childhood Cancer and Blood Diseases, Lucile Packard Children’s Hospital, Stanford (2020 - Present)
Associate Director, Childhood Cancer, Stanford Cancer Institute (2020 - Present)

Professional Education

Board Certification: American Board of Pediatrics, Pediatric Hematology-Oncology (2011)
Fellowship: Childrens Hospital Los Angeles Hematology Oncology Fellowship (2009) CA
Residency: Children's Hospital Los Angeles Pediatric Residency (2006) CA
Medical Education: University of Southern California (2003) CA

Contact

Academic tagruber@stanford.edu

Administrator Shauna Hauf Lead Administrator - Pediatric Hematology/Oncology shauf@stanford.edu Tel: 650-723-8233

Clinical Pediatric Hematology and Oncology 1000 Welch Rd Ste 300 MC 5798 Palo Alto CA 94304 Tel: (650) 723-5535 Fax: (650) 723-5231

2022-23 Courses

Independent Studies
- Out-of-Department Advanced Research Laboratory in Bioengineering
  BIOE 191X (Aut, Win)
- Undergraduate Directed Reading/Research
  PEDS 199 (Win, Spr)

Stanford Advisees

Postdoctoral Faculty Sponsor
Mohammad Balood, Ram Rao, Binay Sahoo

All Publications

Profiles With Related Publications

close
Ash A. Alizadeh, MD/PhD

Moghadam Family Professor
Clinical Focus
Cancer > Lymphoma, Lymphoma, B-Cell Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia, Burkitt Lymphoma, Follicular Lymphoma, Diffuse Large-Cell Lymphomas, Leukemia, Hairy Cell, Lymphoma, B-Cell, Marginal Zone, Hodgkin Disease, Medical Oncology
Research Interests
My research is focused on attaining a better understanding of the initiation, maintenance, and progression of tumors, and their response to current therapies toward improving future treatment strategies. In this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.

Clinically, I specialize in the care of patients with lymphomas, working on translating our findings in prospective cancer clinical trials.

374 Total Publications
close
Michael Amylon

Professor of Pediatrics (Hematology/Oncology) at the Lucile Salter Packard Children's Hospital, Emeritus
Research Interests
Bone marrow transplantation (BMT) is a treatment modality which is being broadly applied to a growing number of disorders. Increasing success with BMT is offering improved survival to pediatric and adult patients with acute leukemia, chronic leukemia, lymphomas, and a variety of solid tumors as well as severe aplastic anemia.

104 Total Publications
close
Alice Bertaina MD, PhD

Associate Professor of Pediatrics (Stem Cell Transplantation)
Clinical Focus
Pediatric Stem Cell Transplantation, Graft engineering, Pediatric Hematology-Oncology

173 Total Publications
close
Michael F. Clarke, M.D.

Karel H. and Avice N. Beekhuis Professor of Cancer Biology
Research Interests
Dr. Clarke maintains a laboratory focused on two areas of research: i) the control of self-renewal of normal stem cells and diseases such as cancer and hereditary diseases; and ii) the identification and characterization of cancer stem cells. His laboratory is investigating how perturbations of stem cell regulatory machinery contributes to human disease. In particular, the laboratory is investigating epigenetic regulators of self renewal, the process by which stem cells regenerate themselves.

180 Total Publications
close
Gary Dahl

Professor of Pediatrics (Hematology/Oncology), Emeritus
Research Interests
Hematology/Oncology, Phase I drug studies for childhood cancer, overcoming multidrug resistance in leukemia and solid tumors, biology and treatment of acute nonlymphocytic leukemia, early detection of central nervous system leukemia by measuring growth, factor binding proteins.

169 Total Publications
close
Sarah S. Donaldson, MD

Catharine and Howard Avery Professor in the School of Medicine, Emerita
Research Interests
Combined Modality Treatment of Cancer
Late Effects of Treatment
Genetic Effects of Cancer
Rhabdomyosarcoma
Hodgkins Disease
Pediatric Radiation Oncolgy
Pediatric Oncolgy
Breast Cancer
Conformal Radiotherapy/IMRT
Radiotherapy for Benign Diseases

302 Total Publications
close
Paul Graham Fisher, MD

Beirne Family Professor of Pediatric Neuro-Oncology, Professor of Pediatrics and, by courtesy, of Neurosurgery and of Epidemiology and Population Health
Clinical Focus
Cancer > Neuro Oncology, Neurology - Child Neurology, Neuro-Oncology, Neurology
Research Interests
Clinical neuro-oncology: My research explores the epidemiology, natural history, and disease patterns of brain tumors in childhood, as well as prospective clinical trials for treating these neoplasms. Research interests also include neurologic effects of cancer and its therapies, and childhood headaches.

266 Total Publications
close
Andrew Gentles

Assistant Professor (Research) of Pathology, of Medicine (BMIR) and, by courtesy, of Biomedical Data Science
Research Interests
Computational systems biology of human disease. Particular focus on integration of high-throughput datasets with each other, and with phenotypic information and clinical outcomes.

108 Total Publications
close
Joachim Hallmayer

Professor of Psychiatry and Behavioral Sciences

233 Total Publications
close
Kathleen Houlahan

Postdoctoral Scholar, Stanford Cancer Center

27 Total Publications
close
Nikolaus Jahn

Postdoctoral Scholar, Pathology

10 Total Publications
close
Norman J. Lacayo, MD

Associate Professor of Pediatrics (Hematology and Oncology)
Clinical Focus
Hematology/Oncology/Stem Cell Transplant, Pediatric, Oncology (Cancer), Pediatric, AML, childhood and adolescent/young adult, ALL, childhood and adolescent/young adult, lymphoblastic lymphoma, childhood, Pediatric Hematology-Oncology
Research Interests
Pediatric Hematology/Oncology, Phase I drug studies for refractory and relapsed leukemia; genomic studies, biologic risk-stratification and treatment of acute myeloid leukemia; prediction or induction response and risk of relapse using phosphoproteomics in childhood AML; novel MRD techniques in childhood ALL.

101 Total Publications